HFNO Versus Nasal CPAP in Obese Patients Undergoing Deep Sedation for ERCP

Launched by ASSIUT UNIVERSITY · Jun 2, 2021

Keywords

ClinConnect Summary

This clinical trial is studying two different methods of providing breathing support for obese patients who are undergoing a procedure called endoscopic retrograde cholangio-pancreatography (ERCP) while under deep sedation. The trial aims to compare High-Flow Nasal Oxygen (HFNO) with Nasal Continuous Positive Airway Pressure (CPAP) to see which method is better at keeping patients safe and comfortable during the procedure. This is important because the medications used for sedation can affect breathing, especially in patients who are overweight.

To participate in this trial, you must be between 18 and 70 years old, have a body mass index (BMI) between 30 and 35, and be scheduled for an elective ERCP procedure that will last longer than 15 minutes. However, patients with a BMI over 35, certain heart or breathing conditions, or those who are pregnant cannot join the study. If you qualify, you can expect to be monitored closely during the procedure to ensure your safety and comfort. The trial is not yet recruiting participants, but it aims to provide valuable insights into improving care for obese patients during sedation.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • patients undergoing elective ERCP with deep sedation will be enrolled
• • age 18 - 70 years old
• • obesity (BMI 30-35 kg/m2)
• • American Society of Anaesthesiologists' physical status classification of 1 to 3
• • Anticipated duration of the procedure is \> 15 minutes.
• Exclusion Criteria:
• • • BMI \>35 kg/m2
• • Simple procedures of \< 15 minutes duration.
• • untreated or unstable cardiac conditions
• • Nasal or oral disease resulting in difficulty of either nasal breathing or mouth breathing.
• • Acute or chronic respiratory disorders as asthma and chronic obstructive pulmonary disease.
• • Pregnant patients and patients having procedures with planned endotracheal intubation
• • Expected difficult intubation patients.